- Our products
- Ocular Health Section
- Research & Innovation
- Fondation Théa
Théa, the European leader in preservative-free eye care products continues its worldwide expansion by opening a new subsidiary in the United States.
“This year, our priority is the American market” declared Jean-Frederic CHIBRET, president of Théa Group.
One year ago, the company decided to create a new commercial subsidiary settled in the region of Boston in the United States. Théa has invested in the capital of Similasan to become a majority shareholder within two years. Indeed, this Swiss company has a strong presence in the United States especially on the market of the OTC remedies.
This partnership is a great opportunity for Théa to enter on this market in the United States and to sell its OTC products on the European market.